Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey (Q41235262)

28 September 2017

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey (English)

1 reference

multicenter clinical trial

28 September 2017

0 references

alcoholic liver disease

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

Satoshi Oeda

20

0 references

Atsushi Nakajima

27

object named as

Atsushi Nakajima

1 reference

28 September 2017

31

Hirokazu Takahashi

1 reference

28 September 2017

36

Kazuaki Chayama

1 reference

28 September 2017

2

Hideyuki Hyogo

1 reference

28 September 2017

8

Yuichi Nozaki

1 reference

28 September 2017

11

Kento Imajo

1 reference

28 September 2017

30

Naohiko Masaki

1 reference

28 September 2017

9

Miwa Kawanaka

1 reference

28 September 2017

18

Kensuke Munekage

1 reference

28 September 2017

5

Takumi Kawaguchi

1 reference

28 September 2017

4

Masafumi Ono

1 reference

28 September 2017

13

Yoshihiro Kamada

1 reference

28 September 2017

12

Yoshio Sumida

1 reference

28 September 2017

29

Ken Nishino

1 reference

28 September 2017

10

Saiyu Tanaka

1 reference

28 September 2017

33

Takuji Torimura

1 reference

28 September 2017

34

Toshiji Saibara

1 reference

28 September 2017

7

Yuichiro Eguchi

1 reference

28 September 2017

1

Katsutoshi Tokushige

1 reference

28 September 2017

3

Tomoaki Nakajima

1 reference

28 September 2017

17

Yoshiyasu Karino

1 reference

28 September 2017

24

Yuya Seko

1 reference

28 September 2017

28

Kazuyuki Kanemasa

1 reference

28 September 2017

32

Masataka Seike

1 reference

28 September 2017

Koichi Honda

6

1 reference

28 September 2017

Hideki Fujii

14

1 reference

28 September 2017

Yasuaki Suzuki

15

1 reference

28 September 2017

Tomomi Kogiso

16

1 reference

28 September 2017

Ryoko Kuromatsu

19

1 reference

28 September 2017

Mikio Yanase

21

1 reference

28 September 2017

Kohjiro Mori

22

1 reference

28 September 2017

Yuji Ogawa

23

1 reference

28 September 2017

Tetsuo Takehara

25

1 reference

28 September 2017

Yoshito Itoh

26

1 reference

28 September 2017

Joji Toyota

35

1 reference

28 September 2017

Etsuko Hashimoto

37

1 reference

28 September 2017

11 October 2015

1 reference

Journal of Gastroenterology

28 September 2017

1 reference

28 September 2017

51

1 reference

28 September 2017

6

1 reference

28 September 2017

586-596

1 reference

Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.

28 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Increasing prevalence of diabetes mellitus in association with fatty liver in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Etiology of liver cirrhosis in Japan: a nationwide survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients. American Diabetes Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Hepatocellular carcinoma based on cryptogenic liver disease: The most common non-viral hepatocellular carcinoma in patients aged over 80 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

What studies on human longevity tell us about the risk for cancer in the oldest old: data and hypotheses on the genetics and immunology of centenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Base excision repair of oxidative DNA damage and association with cancer and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Primary liver cancers with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Sectionectomy is suitable for patients with T2 hepatocellular carcinoma according to the modified international union against cancer TNM Classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Induction of cross-linking and silencing of Sp1 by transglutaminase during liver injury in ASH and NASH via different ER stress pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Report of the 18th follow-up survey of primary liver cancer in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-015-1129-1

A variant of des-gamma-carboxy prothrombin was increased in alcoholic liver disease without hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan

1 reference

12 December 2020

Nonalcoholic steatohepatitis: risk factors for liver fibrosis

1 reference

12 December 2020

Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography

1 reference

12 December 2020

Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes

1 reference

12 December 2020

[The history of the diagnostic criteria for alcoholic liver disease and current status of alcoholic liver disease in Japan]

1 reference

12 December 2020

Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C

1 reference

12 December 2020

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

12 December 2020

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S00535-015-1129-1

Identifiers

DOI

1 reference

28 September 2017

1 reference